Malaria Parasite Protein Shows Promise as Cancer Therapeutic

News   Apr 21, 2017 | Original story from The University of British Columbia

 
Malaria Parasite Protein Shows Promise as Cancer Therapeutic

Photo: James Gathany, CDC.

 
 
 
 

RELATED NEWS

Academic Redesigns FDA-Approved MabThera to Treat ALS

News

Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.

READ MORE

Liver Fluke Granulin Structural Fold Provides Wound Healing Opportunity

News

Researchers can now mass produce wound-healing peptides isolated from the spit of the human parasitic liver fluke, a worm that causes liver cancer and kills 26,000 people in Thailand each year.

READ MORE

Biogen's MS Drug FAMPYRA Granted Standard Marketing Authorization in EU

News

Biogen's drug FAMPYRA improves walking for MS sufferers and has been granted standard marketing authorization.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE